Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment

Conditions:   Chronic Myelogenous Leukemia, BCR-ABL Positive;   CML, Chronic Phase Intervention:   Drug: Pioglitazone 15mg Sponsor:   Mansoura University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials